Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
12 2019
Historique:
accepted: 24 03 2019
pubmed: 29 3 2019
medline: 16 3 2021
entrez: 29 3 2019
Statut: ppublish

Résumé

Hidradenitis suppurativa (HS), also referred to as acne inversa, is a debilitating skin disease characterized by inflammatory nodules, chronic abscesses and tunnels (fistulae and sinuses). The association with pilonidal sinus disease (PSD) is frequently reported but not well documented. To determine the prevalence and characteristics of inflammatory skin lesions located in the intergluteal fold (IGF) of patients with HS. This was an international multicentre retrospective cross-sectional study based on data collection from a large cohort of patients with HS with and without histopathology. Results From a total of 2465 patients with HS included in the study, 661 (27%) reported lesions in the IGF. These patients were significantly more often smokers and had more severe HS. Of the 238 patients with an available clinical diagnosis, intergluteal-HS (IG-HS) was diagnosed in 52 patients (22%) and PSD was diagnosed in 186 patients (78%). IG-HS was associated with the localization of HS in the proximity of the IGF, including the buttocks, genitals and the anus. There was a possibility of misclassification bias in this study as a clinical/image-based diagnosis or histopathology of the IGF lesions was not always available. The high prevalence of PSD suggests a strong link between both entities. Therefore, it may be useful to identify common pathophysiological mechanisms and develop common therapeutic strategies. What's already known about this topic? The occurrence of pilonidal sinus disease has not been clearly reported among patients with hidradenitis suppurativa/acne inversa. What does this study add? This is the first study that investigated the prevalence of pilonidal sinus disease among a large cohort of patients and identified the patient characteristics. Risk factors that might help to improve the management of patients were identified.

Sections du résumé

BACKGROUND
Hidradenitis suppurativa (HS), also referred to as acne inversa, is a debilitating skin disease characterized by inflammatory nodules, chronic abscesses and tunnels (fistulae and sinuses). The association with pilonidal sinus disease (PSD) is frequently reported but not well documented.
OBJECTIVES
To determine the prevalence and characteristics of inflammatory skin lesions located in the intergluteal fold (IGF) of patients with HS.
METHODS
This was an international multicentre retrospective cross-sectional study based on data collection from a large cohort of patients with HS with and without histopathology. Results From a total of 2465 patients with HS included in the study, 661 (27%) reported lesions in the IGF. These patients were significantly more often smokers and had more severe HS. Of the 238 patients with an available clinical diagnosis, intergluteal-HS (IG-HS) was diagnosed in 52 patients (22%) and PSD was diagnosed in 186 patients (78%). IG-HS was associated with the localization of HS in the proximity of the IGF, including the buttocks, genitals and the anus. There was a possibility of misclassification bias in this study as a clinical/image-based diagnosis or histopathology of the IGF lesions was not always available.
CONCLUSIONS
The high prevalence of PSD suggests a strong link between both entities. Therefore, it may be useful to identify common pathophysiological mechanisms and develop common therapeutic strategies. What's already known about this topic? The occurrence of pilonidal sinus disease has not been clearly reported among patients with hidradenitis suppurativa/acne inversa. What does this study add? This is the first study that investigated the prevalence of pilonidal sinus disease among a large cohort of patients and identified the patient characteristics. Risk factors that might help to improve the management of patients were identified.

Identifiants

pubmed: 30919434
doi: 10.1111/bjd.17927
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1198-1206

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 British Association of Dermatologists.

Références

Duman K, Harlak A, Mentes O, Coskun AK. Predisposition and risk factor rates for pilonidal sinus disease. Asian J Surg 2016; 39:120-1.
Doll D, Friederichs J, Dettmann H et al. Time and rate of sinus formation in pilonidal sinus disease. Int J Colorectal Dis 2008; 23:359-64.
Gasparic J, Theut Riis P, Jemec GB. Recognizing syndromic hidradenitis suppurativa: a review of the literature. J Eur Acad Dermatol Venereol 2017; 31:1809-16.
Hotz C, Boniotto M, Guguin A et al. Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. J Invest Dermatol 2016; 136:1768-80.
Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 2015; 73(Suppl. 1):S8-11.
Vasanth V, Chandrashekar BS. Follicular occlusion tetrad. Indian Dermatol Online J 2014; 5:491-3.
von Laffert M, Stadie V, Ulrich J et al. Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa. Dermatology 2011; 223:349-55.
Canoui-Poitrine F, Le Thuaut A, Revuz JE et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol 2013; 133:1506-11.
Wortsman X, Castro A, Morales C et al. Sonographic comparison of morphologic characteristics between pilonidal cysts and hidradenitis suppurativa. J Ultrasound Med 2017; 36:2403-18.
Ciftci F, Abdurrahman I. A different disease: extrasacrococcygeal pilonidal sinuses etiopathogenesis. Int J Clin Exp Med 2015; 8:11567-71.
Vazquez BG, Alikhan A, Weaver AL et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013; 133:97-103.
Wiltz O, Schoetz DJ Jr, Murray JJ et al. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum 1990; 33:731-4.
Kromann CB, Deckers IE, Esmann S et al. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol 2014; 171:819-24.
Canoui-Poitrine F, Revuz JE, Wolkenstein P et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009; 61:51-7.
Santos JV, Lisboa C, Lanna C et al. Hospitalisations with hidradenitis suppurativa: an increasing problem that deserves closer attention. Dermatology 2016; 232:613-18.
Zouboulis CC, Del Marmol V, Mrowietz U et al. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015; 231:184-90.
Akinci OF, Bozer M, Uzunkoy A et al. Incidence and aetiological factors in pilonidal sinus among Turkish soldiers. Eur J Surg 1999; 165:339-42.
Aysan E, Ilhan M, Bektas H et al. Prevalence of sacrococcygeal pilonidal sinus as a silent disease. Surg Today 2013; 43:1286-9.
Duman K, Girgin M, Harlak A. Prevalence of sacrococcygeal pilonidal disease in Turkey. Asian J Surg 2017; 40:434-7.
Dwight RW, Maloy JK. Pilonidal sinus; experience with 449 cases. N Engl J Med 1953; 249:926-30.
Yildiz T, Elmas B, Yucak A et al. Risk factors for pilonidal sinus disease in teenagers. Indian J Pediatr 2017; 84:134-8.
Harlak A, Mentes O, Kilic S et al. Sacrococcygeal pilonidal disease: analysis of previously proposed risk factors. Clinics (Sao Paulo) 2010; 65:125-31.
Hull TL, Wu J. Pilonidal disease. Surg Clin North Am 2002; 82:1169-85.
Bolandparvaz S, Moghadam Dizaj P, Salahi R et al. Evaluation of the risk factors of pilonidal sinus: a single center experience. Turk J Gastroenterol 2012; 23:535-7.
Sievert H, Evers T, Matevossian E et al. The influence of lifestyle (smoking and body mass index) on wound healing and long-term recurrence rate in 534 primary pilonidal sinus patients. Int J Colorectal Dis 2013; 28:1555-62.
Karydakis GE. Easy and successful treatment of pilonidal sinus after explanation of its causative process. Aust N Z J Surg 1992; 62:385-9.

Auteurs

F Benhadou (F)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
ResoVerneuil, Paris, France.
European Hidradenitis Suppurativa Foundation e.V., Europe.

H H Van der Zee (HH)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

J C Pascual (JC)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain.

D Rigopoulos (D)

2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

A Katoulis (A)

European Hidradenitis Suppurativa Foundation e.V., Europe.
2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

A I Liakou (AI)

European Hidradenitis Suppurativa Foundation e.V., Europe.
2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

M Daxhelet (M)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
European Hidradenitis Suppurativa Foundation e.V., Europe.

M Romanelli (M)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, University of Pisa, Pisa, Italy.

M Iannone (M)

Department of Dermatology, University of Pisa, Pisa, Italy.

Á Kinyó (Á)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Venereology and Oncodermatology, University of Pécs, Medical School, Pécs, Hungary.

G Nikolakis (G)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany.

C C Zouboulis (CC)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany.

C Dessinioti (C)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece.

C Zisimou (C)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece.

C Antoniou (C)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece.

A Alavi (A)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, York Dermatology Center, Richmond Hill, ON, U.S.A.

D Mintoff (D)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Sir Paul Boffa Hospital, Floriana, Malta.

S Aquilina (S)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Sir Paul Boffa Hospital, Floriana, Malta.

L Matusiak (L)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Allergology and Venereology, Wroclaw Medical University, Wroclaw, Poland.

J C Szepietowski (JC)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Allergology and Venereology, Wroclaw Medical University, Wroclaw, Poland.

R Sinclair (R)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Epworth Hospital, University of Melbourne, Melbourne, Australia.

H Husein-ElAhmed (H)

Department of Dermatology, Hospital de Baza, Granada, Spain.

M von Laffert (M)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Institute of Pathology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.

J Revuz (J)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Private Practice, Paris, France.

B Danby (B)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Geisel School of Medicine at Dartmouth, Manchester, NH, U.S.A.

L Puig (L)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

P Theut Riis (P)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Zealand University Hospital, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark.

G B E Jemec (GBE)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Zealand University Hospital, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark.

K van Straalen (K)

European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

K M G J Wigny (KMGJ)

Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

V Del Marmol (V)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
European Hidradenitis Suppurativa Foundation e.V., Europe.

P Guillem (P)

ResoVerneuil, Paris, France.
European Hidradenitis Suppurativa Foundation e.V., Europe.
Department of Surgery, Clinique du Val d'Ouest, Ecully, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH